Lista de obras - Xiang-Ming Lao - Dominio Público Uruguay

A gastrointestinal stromal tumor of the jejunum associated with intrahepatic cholangiocarcinoma and pulmonary hamartoma: a case report

artículo científico publicado en 2009

A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma

artículo científico publicado en 2015

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.

artículo científico publicado en 2016

Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression ⬇️

artículo científico publicado el 20 de junio de 2011

Adsorption and sustained release of epirubicin from carbon-coated iron nanocrystals

artículo científico publicado en 2008

Antiviral therapy in patients with hepatitis B virus-related hepatocellular carcinoma: is it ready for universal application?

artículo científico publicado en 2013

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection.

artículo científico publicado en 2016

B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis

scientific article published on 09 September 2020

B lymphocytes as effector cells in the immunotherapy of cancer ⬇️

artículo científico publicado el 6 de septiembre de 2011

B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets

artículo científico publicado en 2014

Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma.

artículo científico publicado en 2011

Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.

artículo científico publicado en 2016

Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma.

artículo científico publicado en 2015

Clinical conditions and treatment requirements for long-term survival among hepatitis B-related hepatocellular carcinoma initially treated with chemoembolization

scientific article published on 17 July 2019

Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study ⬇️

artículo científico publicado el 17 de abril de 2012

Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma.

artículo científico publicado en 2016

Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma

scientific article published on 28 February 2019

Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.

artículo científico publicado en 2013

Effects of carbon-coated iron nanocrystals combined with epirubicin on HepG-2 cells and its acute toxicity in mice

artículo científico publicado en 2008

Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.

artículo científico publicado en 2015

Hepatic resection for synchronous hepatic metastasis from gastric cancer.

artículo científico publicado en 2013

Hepatitis B virus reactivation and liver function after chemoembolization for hepatocellular carcinoma: How is it different from systemic chemotherapy?

artículo científico publicado en 2013

Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment

artículo científico publicado en 2017

Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis

artículo científico publicado en 2015

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

artículo científico publicado en 2015

Impact of overweightness and critical weight loss on overall survival in patients with hepatocellular carcinoma initially treated with chemoembolization

artículo científico publicado en 2019

Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells.

artículo científico publicado en 2012

Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.

artículo científico publicado en 2013

PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression.

artículo científico publicado en 2016

Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma.

artículo científico publicado en 2016

Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice

artículo científico publicado en 2019

Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization.

artículo científico publicado en 2016

Primary clear cell carcinoma of liver--clinicopathologic features and surgical results of 18 cases

scientific article published on 01 January 2006

Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.

artículo científico publicado en 2017

Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

artículo científico publicado en 2015

Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma

artículo científico publicado en 2017

Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma.

artículo científico publicado en 2014

[Acute toxicity of carbon-coated iron nanocrystal and its effect on liver and kidney functions and hematological system]

artículo científico publicado en 2007

[Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure]

scientific article published on 01 March 2005

[Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma]

artículo científico publicado en 2004

Lista de obras de Xiang-Ming Lao

A gastrointestinal stromal tumor of the jejunum associated with intrahepatic cholangiocarcinoma and pulmonary hamartoma: a case report

A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.

Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression ⬇️

Adsorption and sustained release of epirubicin from carbon-coated iron nanocrystals

Antiviral therapy in patients with hepatitis B virus-related hepatocellular carcinoma: is it ready for universal application?

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection.

B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis

B lymphocytes as effector cells in the immunotherapy of cancer ⬇️

B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets

Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma.

Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.

Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma.

Clinical conditions and treatment requirements for long-term survival among hepatitis B-related hepatocellular carcinoma initially treated with chemoembolization

Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study ⬇️

Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma.

Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma

Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.

Effects of carbon-coated iron nanocrystals combined with epirubicin on HepG-2 cells and its acute toxicity in mice

Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.

Hepatic resection for synchronous hepatic metastasis from gastric cancer.

Hepatitis B virus reactivation and liver function after chemoembolization for hepatocellular carcinoma: How is it different from systemic chemotherapy?

Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment

Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

Impact of overweightness and critical weight loss on overall survival in patients with hepatocellular carcinoma initially treated with chemoembolization

Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells.

Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.

PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression.

Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma.

Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice

Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization.

Primary clear cell carcinoma of liver--clinicopathologic features and surgical results of 18 cases

Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.

Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma

Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma.

[Acute toxicity of carbon-coated iron nanocrystal and its effect on liver and kidney functions and hematological system]

[Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure]

[Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma]